- Filed
- May 10, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 6, 2024 | 72.03M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 75.16M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 85.34M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | $24.74M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $35.7M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $338.22M |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $357.41M |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $56.21M |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $43.31M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $82.2M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $76.26M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $362.87M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $354.05M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $349.4M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $339.69M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $174.15M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $169.49M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $733.97M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $724.83M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $115.97M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $114.59M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $1.1B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $1.08B |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | $0.19 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.14 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | $0.20 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.15 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $10.35M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $7.84M |
| Net Income | Q1 2024 · Mar 31, 2024 | $14.64M |
| Net Income | Q1 2024 · Mar 31, 2023 | $12.14M |
| Operating Income | Q1 2024 · Mar 31, 2024 | $23.49M |
| Operating Income | Q1 2024 · Mar 31, 2023 | $22.54M |
| Revenue | Q1 2024 · Mar 31, 2024 | $117.5M |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $113.79M |